|
US5846983A
(en)
*
|
1996-02-09 |
1998-12-08 |
Mayo Foundation For Medical Education And Research |
Colonic delivery of nicotine to treat inflammatory bowel disease
|
|
NZ504188A
(en)
*
|
1997-11-14 |
2001-10-26 |
Skyepharma Inc |
Emulsification process for preparing multivesicular liposomes
|
|
US6723358B1
(en)
|
1998-03-23 |
2004-04-20 |
General Mills, Inc. |
Encapsulation of components into edible products
|
|
AUPP627498A0
(en)
|
1998-10-02 |
1998-10-22 |
University Of Queensland, The |
Novel peptides - i
|
|
DE19847715A1
(de)
*
|
1998-10-16 |
2000-04-20 |
Lohmann Therapie Syst Lts |
Verfahren zur Behandlung der Schizophrenie sowie Mittel zur Verwendung in diesem Verfahren
|
|
ES2226933T3
(es)
*
|
1999-11-01 |
2005-04-01 |
John Rhodes |
Composicion para tratar el estreñimiento y el sindrome del intestino irritable.
|
|
US6468568B1
(en)
|
2000-06-16 |
2002-10-22 |
General Mills, Inc. |
Oligosaccharide encapsulated mineral and vitamin ingredients
|
|
US6436453B1
(en)
|
2000-06-16 |
2002-08-20 |
General Mills, Inc. |
Production of oil encapsulated minerals and vitamins in a glassy matrix
|
|
NZ524423A
(en)
*
|
2000-08-03 |
2004-04-30 |
Antares Pharma Ipl Ag |
A composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
CA2341952A1
(en)
|
2001-03-23 |
2002-09-23 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
|
|
US7081475B2
(en)
|
2001-09-14 |
2006-07-25 |
Prolx Pharmaceuticals Corp. |
Wortmannin analogs and methods of using same
|
|
US20040037879A1
(en)
*
|
2001-11-02 |
2004-02-26 |
Adusumilli Prasad S. |
Oral controlled release forms useful for reducing or preventing nicotine cravings
|
|
US8557804B2
(en)
|
2002-03-25 |
2013-10-15 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory diseases
|
|
US8039459B2
(en)
|
2004-07-15 |
2011-10-18 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory diseases
|
|
ATE547424T1
(de)
|
2002-12-02 |
2012-03-15 |
Xenome Ltd |
Chi-conotoxinpeptide mit einer n-terminalen pyroglutaminsäure
|
|
EP2412719A1
(en)
|
2002-12-02 |
2012-02-01 |
Xenome Ltd |
Chi-conotoxin peptides
|
|
JP5294559B2
(ja)
*
|
2003-07-03 |
2013-09-18 |
スキャンポ・アーゲー |
クロライドチャンネルオープナーとしてプロスタグランジンアナログを含む腸溶性組成物
|
|
CN100508976C
(zh)
|
2003-07-24 |
2009-07-08 |
史密丝克莱恩比彻姆公司 |
口腔溶解薄膜
|
|
US20060275253A1
(en)
*
|
2003-09-01 |
2006-12-07 |
Kazunari Ushida |
Beta hydroxy short to medium chain fatty acid polymer
|
|
JP5619337B2
(ja)
|
2003-10-10 |
2014-11-05 |
フェリング ビー．ブイ． |
皮膚残渣を最小限に抑えるための経皮的医薬製剤
|
|
US20050287212A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Liang-Chang Dong |
Oral delivery system comprising a drug/polymer complex
|
|
US7780981B2
(en)
|
2004-09-13 |
2010-08-24 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
WO2006125642A1
(en)
*
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
|
WO2007041314A2
(en)
*
|
2005-09-30 |
2007-04-12 |
Tti Ellebeau, Inc. |
Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
|
|
KR20080066712A
(ko)
*
|
2005-09-30 |
2008-07-16 |
티티아이 엘뷰 가부시키가이샤 |
관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
|
|
JP2009509634A
(ja)
*
|
2005-09-30 |
2009-03-12 |
Ｔｔｉ・エルビュー株式会社 |
官能基化マイクロニードル経皮薬剤送達システム、装置及び方法
|
|
US7803413B2
(en)
|
2005-10-31 |
2010-09-28 |
General Mills Ip Holdings Ii, Llc. |
Encapsulation of readily oxidizable components
|
|
NZ571460A
(en)
|
2006-04-21 |
2010-10-29 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
|
CN104224823A
(zh)
|
2007-03-30 |
2014-12-24 |
有限会社爱泽世 |
生酮作用促进剂组合物
|
|
JP2010523587A
(ja)
*
|
2007-04-02 |
2010-07-15 |
パーキンソンズ インスティテュート |
治療処置の副作用の低減のための方法および組成物
|
|
CN101801359B
(zh)
*
|
2007-05-18 |
2013-11-06 |
Tti优而美株式会社 |
确保有效成分经生物界面增加释放的透皮递送设备
|
|
TW200948383A
(en)
*
|
2008-05-19 |
2009-12-01 |
Univ Nat Taiwan |
System for determining function of intestinal barrier
|
|
US20110268809A1
(en)
|
2010-04-28 |
2011-11-03 |
Paul Andrew Brinkley |
Nicotine-Containing Pharmaceutical Compositions
|
|
US20110274628A1
(en)
|
2010-05-07 |
2011-11-10 |
Borschke August J |
Nicotine-containing pharmaceutical compositions
|
|
DK2654738T3
(en)
*
|
2010-12-21 |
2018-07-23 |
Fertin Pharma As |
CHEESE GUM COMPOSITION COMPREHENSIVE CROSS-POLYACRYLIC ACID
|
|
WO2013006643A1
(en)
*
|
2011-07-06 |
2013-01-10 |
The Parkinson's Institute |
Compositions and methods for treatment of symptoms in parkinson's disease patients
|
|
US20130078307A1
(en)
|
2011-09-22 |
2013-03-28 |
Niconovum Usa, Inc. |
Nicotine-containing pharmaceutical composition
|
|
US9907748B2
(en)
|
2011-10-21 |
2018-03-06 |
Niconovum Usa, Inc. |
Excipients for nicotine-containing therapeutic compositions
|
|
US9763928B2
(en)
|
2012-02-10 |
2017-09-19 |
Niconovum Usa, Inc. |
Multi-layer nicotine-containing pharmaceutical composition
|
|
IN2014DN10260A
(en:Method)
*
|
2012-06-15 |
2015-08-07 |
Conaris Res Inst Ag |
|
|
US20150231130A1
(en)
|
2012-07-26 |
2015-08-20 |
Wockhardt Limited |
Pharmaceutical composition comprising diamorphine for intranasal administration
|
|
US20140255452A1
(en)
|
2013-03-11 |
2014-09-11 |
Niconovum Usa, Inc. |
Method and apparatus for differentiating oral pouch products
|
|
JP6895752B2
(ja)
|
2013-12-13 |
2021-06-30 |
コナリス リサーチ インスティチュート アーゲー |
ニコチン酸および／またはニコチンアミドを含む、腸内微生物叢を改変することにより血中脂質レベルに有益に影響を及ぼすための医薬組成物
|
|
JP6554468B6
(ja)
|
2013-12-13 |
2019-09-11 |
コナリス リサーチ インスティチュート アーゲー |
ニコチンアミドと５−アミノサリチル酸との組合せを含有する、腸内微生物叢に有益な影響を及ぼすため、かつ／または胃腸の炎症を処置するための医薬組成物
|
|
EP3154530B1
(en)
*
|
2014-06-10 |
2018-04-04 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Nanoparticulate complex of nicotine and cerium oxide and use thereof
|
|
JP2018511355A
(ja)
|
2015-01-28 |
2018-04-26 |
クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
薬剤送達方法及びシステム
|
|
AU2016228779A1
(en)
|
2015-03-12 |
2017-09-07 |
Chrono Therapeutics Inc. |
Craving input and support system
|
|
US9993426B2
(en)
|
2015-09-15 |
2018-06-12 |
C. B. Fleet Company, Inc. |
Bisacodyl compositions and delivery apparatus
|
|
US10532046B2
(en)
|
2015-12-03 |
2020-01-14 |
Niconovum Usa, Inc. |
Multi-phase delivery compositions and products incorporating such compositions
|
|
US20170165252A1
(en)
|
2015-12-10 |
2017-06-15 |
Niconovum Usa Inc. |
Protein-enriched therapeutic composition
|
|
US10292977B2
(en)
|
2016-04-11 |
2019-05-21 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
|
US10143687B2
(en)
|
2016-04-11 |
2018-12-04 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
|
WO2018113916A1
(en)
*
|
2016-12-20 |
2018-06-28 |
Fertin Pharma A/S |
A mucoadhesive oromucosal formulation comprising a nicotine complex
|
|
JP2020503950A
(ja)
|
2017-01-06 |
2020-02-06 |
クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
経皮薬剤送達の装置及び方法
|
|
EP3801732A4
(en)
|
2018-05-29 |
2022-04-27 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
EP3807260B1
(en)
|
2018-06-15 |
2024-09-18 |
R. J. Reynolds Tobacco Company |
Purification of nicotine
|
|
WO2020102695A1
(en)
|
2018-11-16 |
2020-05-22 |
Cti (Assignment For Benefit Of Creditors) Llc |
Thermally regulated transdermal drug delivery system
|